You are here
COVID-19 drug Paxlovid has been free; next year, sticker shock awaits
Primary tabs
Thu, 2022-12-08 19:11 — mike kraft
COVID-19 drug Paxlovid has been free; next year, sticker shock awaits Nearly 6 million Americans have taken Paxlovid for free, courtesy of the federal government. But the government plans to stop footing the bill within months. UPI
![](https://cdnph.upi.com/sv/ph/og/upi_com/4751670504674/2022/1/84c197678b5a83b1200f38af6d91aa24/v1.5/COVID-19-drug-Paxlovid-has-been-free-next-year-sticker-shock-awaits.jpg)
... soon the Department of Health and Human Services will stop supplying COVID-19 treatments, and pharmacies will purchase and bill for them the same way they do for antibiotic pills or asthma inhalers. Paxlovid is expected to hit the private market in mid-2023, according to HHS plans shared in an October meeting with state health officials and clinicians. Merck's Lagevrio, a less-effective COVID-19 treatment pill, and AstraZeneca's Evusheld, a preventive therapy for the immunocompromised, are on track to be commercialized sooner, sometime in the winter.
...
Country / Region Tags:
General Topic Tags:
Problem, Solution, SitRep, or ?:
Groups this Group Post belongs to:
- Private group -
Recent Comments